• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Alerta OMS a farmac?uticas para desarrollar vacunas - WHO alerts pharma industry about perhaps making vaccine

FrenchieGirl

Senior Moderator
http://usa.invertia.com/noticias/noticia.aspx?idNoticia=200904242153_TRM_78019270&idtel=

M?XICO
Alerta OMS a farmac?uticas para desarrollar vacunas

BRUSELAS, B?LGICA, Abril. 24.- La Organizaci?n Mundial de la Salud (OMS) inici? pl?ticas con farmac?uticas para que est?n alerta y eventualmente desarrollen una posible vacuna que neutralice al virus de gripe porcina que ha brotado en M?xico.

"La OMS est? analizando muy seriamente la situaci?n y estamos muy preocupados por lo que est? ocurriendo en M?xico", dijo a REFORMA Aphaluck Bhatiaseve, experta en influenza de la OMS.

"Por lo pronto, ya contactamos a empresas farmac?uticas para que est?n listas en caso de que tengan que mover su producci?n de vacunas a una de niveles de pandemia".

"Pero antes debemos saber si hay vacuna capaz de proteger a la poblaci?n, porque al parecer es un nuevo virus y lo que hay disponible en el mercado aparentemente s?lo ofrece una protecci?n m?nima".

La producci?n masiva de vacunas no ser?a ?nicamente para ayudar a M?xico, sino para responder ante el eventual brote del virus en otras partes del mundo.

Para determinar si es necesario activar los laboratorios farmac?uticos, la OMS convoc? de urgencia a su comit? cient?fico para analizar la situaci?n en M?xico.

Los epidemi?logos internacionales se reunir?n en Ginebra este s?bado para descifrar la estructura gen?tica del virus y determinar si es posible desarrollar el ant?doto vacuna.

Los cient?ficos tambi?n tienen la encomienda de determinar si se decreta el nivel de alerta por pandemia, lo que implicar?a adoptar medidas adicionales de precauci?n.

Las medidas de contingencia para evitar la propagaci?n del virus podr?an tener caracter?sticas similares a los planes de acci?n implementados en Europa para contener brotes de la gripe aviar H5N1, como ser?a el dise?o de cercos demogr?ficos y la intensificaci?n de la vigilancia.

El an?lisis ser? con base a la informaci?n proporcionada por el equipo de investigaci?n de la OMS en M?xico y de los contactos que ha establecido directamente la directora del organismo, Margaret Chan, con autoridades mexicanas y estadounidenses.

Por lo pronto, Bhatiaseve reiter? el llamado a extremar precauciones para evitar su propagaci?n.

La Organizaci?n Mundial de la Salud (OMS) cifra en 800 los casos sospechosos de gripe porcina, con 57 posibles muertes, 12 de ellas confirmadas. La OMS est? dispuesta a proporcionar asistencia t?cnica, as? como estrategias y equipo en caso de que se requiera adoptar medidas de contingencia adicionales.

Fuente: GRUPO REFORMA

Google translation

MEXICO
Alert WHO to develop vaccines to pharmaceutical
BRUSSELS, BELGIUM, April. 24 .- The World Health Organization (WHO) began talks with pharmacists to be alert and eventually develop a vaccine that can neutralize the virus of swine flu that has sprung up in Mexico.

"The WHO is examining the situation very seriously and we are very concerned about what is happening in Mexico," said Aphaluck Bhatiaseve Reforma, influenza expert at WHO.

"For one thing, and contacted pharmaceutical companies that are ready in case they need to move its production of vaccines for a pandemic levels.

"But first we must know if a vaccine capable of protecting the population, apparently because a virus is and what is available in the market apparently offers only minimal protection."

The mass production of vaccines would not only be to help Mexico, but to respond to any outbreak of the virus in other parts of the world.

To determine whether to activate the pharmaceutical laboratories, WHO convened its emergency committee to discuss the situation in Mexico.

International epidemiologists will meet in Geneva on Saturday to decipher the genetic structure of the virus and determine whether it is possible to develop the antidote vaccine.

Scientists also have the task of determining whether ordered by the level of pandemic alert, which would take additional precautionary measures.

Contingency arrangements to prevent the spread of the virus may have similar characteristics to the action plans implemented in Europe to contain outbreaks of avian influenza H5N1, as would be the demographic layout of fences and the intensification of surveillance.

The analysis is based on information provided by the research team of the WHO in Mexico and the contacts he has established a direct agency director, Margaret Chan, Mexican and U.S. authorities.

For now, Bhatiaseve reiterated the call for extra precautions to prevent its spread.

The World Health Organization (WHO) estimates that 800 suspected cases of swine flu, with 57 possible deaths, 12 were confirmed. WHO is ready to provide technical assistance as well as strategies and equipment where required additional contingency measures.

Source: REFORM GROUP
 
Back
Top Bottom